1. Hosono, Naoko. 2019. Genetic abnormalities and pathophysiology of MDS. In International journal of clinical oncology, 24, 885-892. doi:10.1007/s10147-019-01462-6. https://pubmed.ncbi.nlm.nih.gov/31093808/
2. Yue, Qu, Wang, Zhao, Shen, Yixiong, Liu, Boyang, Guo, Hongbo. 2024. Histone H3K9 Lactylation Confers Temozolomide Resistance in Glioblastoma via LUC7L2-Mediated MLH1 Intron Retention. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 11, e2309290. doi:10.1002/advs.202309290. https://pubmed.ncbi.nlm.nih.gov/38477507/
3. Jourdain, Alexis A, Begg, Bridget E, Mick, Eran, Burge, Christopher B, Mootha, Vamsi K. 2021. Loss of LUC7L2 and U1 snRNP subunits shifts energy metabolism from glycolysis to OXPHOS. In Molecular cell, 81, 1905-1919.e12. doi:10.1016/j.molcel.2021.02.033. https://pubmed.ncbi.nlm.nih.gov/33852893/
4. Sharifnia, Tanaz, Wawer, Mathias J, Goodale, Amy, Clemons, Paul A, Schreiber, Stuart L. 2023. Mapping the landscape of genetic dependencies in chordoma. In Nature communications, 14, 1933. doi:10.1038/s41467-023-37593-8. https://pubmed.ncbi.nlm.nih.gov/37024492/
5. Singh, H, Lane, A A, Correll, M, Maciejewski, J, Attar, E C. 2013. Putative RNA-splicing gene LUC7L2 on 7q34 represents a candidate gene in pathogenesis of myeloid malignancies. In Blood cancer journal, 3, e117. doi:10.1038/bcj.2013.16. https://pubmed.ncbi.nlm.nih.gov/23708642/
6. Shen, Lin, Li, Chao, Chen, Fang, Li, Zhanzhan, Li, Na. 2021. CRISPR/Cas9 genome-wide screening identifies LUC7L2 that promotes radioresistance via autophagy in nasopharyngeal carcinoma cells. In Cell death discovery, 7, 392. doi:10.1038/s41420-021-00783-8. https://pubmed.ncbi.nlm.nih.gov/34907164/
7. Szelest, Monika, Giannopoulos, Krzysztof. 2024. Biological relevance of alternative splicing in hematologic malignancies. In Molecular medicine (Cambridge, Mass.), 30, 62. doi:10.1186/s10020-024-00839-2. https://pubmed.ncbi.nlm.nih.gov/38760666/
智鼠故事 
